The role of STATs in proliferation, differentiation, and apoptosis

Cellular and Molecular Life Sciences

Volumn 55, Issue 12, 1999, Pages 1547-1558

  Mui, A L F ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apoptosis; Differentiation; Oncogenesis; Proliferation; STAT

Indexed keywords

CYTOKINE; INTERFERON; STAT1 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN;

APOPTOSIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; GENE CONTROL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MICE; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 0032877019     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050394     Document Type: Review

References (125)

1. Darnell J. E. Jr. Kerr I. M. and Stark G. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421
2. Decker T. and Meinke A. (1997) Jaks, Stats and the immune system. Immunobiology 198: 99-111
3. Schindler C. and Darnell J. E. Jr (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64: 621-651
4. Pellegrini S. and Dusanter-Fourt I. (1997) The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur. J. Biochem. 248: 615-633
5. Chin Y. E., Kitagawa M., Su W. C., You Z. H., Iwamoto Y. and Fu X. Y. (1996) Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAFI/CIPI mediated by STAT1. Science 272: 719-722
6. Chellappan S. P., Giordano A. and Fisher P. B. (1998) Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr. Top. Microbiol. Immunol. 227: 57-103
7. Sherr C. J. and Roberts J. M. (1995) Inhibitors of mammalian GI cyclin-dependent kinases. Genes Dev. 9: 1149-1163
8. Sato T., Selleri C., Young N. S. and Maciejewski J. P. (1997) Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. Blood 90: 4749-4758
9. Grimley P. M., Fang H., Rui H., Petricoin E. F. 3rd, Ray S., Dong F. et al. (1998) Prolonged STAT1 activation related to the growth arrest of malignant lymphoma cells by interferon-alpha. Blood 91: 3017-3027
10. Bromberg J. F., Fan Z., Brown C., Mendelsohn J. and Darnell J. E. Jr (1998) Epidermal growth factor-induced growth inhibition requires Stat1 activation. Cell Growth Differ. 9: 505-512
11. Xie W., Su K., Wang D., Paterson A. J. and Kudlow J. E. (1997) MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21WAFI. Anticancer Res. 17: 2627-2633
12. Johnson M. R., Valentine C., Basilico C. and Mansukhani A. (1998) FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells. Oncogene 16: 2647-2656
13. Su W. C., Kitagawa M., Xue N., Xie B., Garofalo S., Cho J. et al. (1997) Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386: 288-292
14. Narimatsu M., Nakajima K., Ichiba M. and Hirano T. (1997) Association of Stat3-dependent transcriptional activation of p19INK4D with IL-6-induced growth arrest. Biochem. Biophys. Res. Commun. 238: 764-768
15. O'Farrell A. M., Liu Y., Moore K. W. and Mui A. L. (1998) IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J. 17: 1006-1018
16. Chaturvedi P., Sharma S. and Reddy E. P. (1997) Abrogation of interleukin-3 dependence of mycloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs. Mol. Cell. Biol. 17: 3295-3304
17. Chaturvedi P., Reddy M. V. and Reddy E. P. (1998) Src kinases and not JAKs activate STATs during IL-3 induced mycloid cell proliferation. Oncogene 16: 1749-1758
18. Marrero M. B., Schieffer B., Li B., Sun J., Harp J. B. and Ling B. N. (1997) Role of Janus kinase signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J. Biol. Chem. 272: 24684-24690
19. Quelle F. W., Sato N., Witthuhn B. A., Inhorn R. C., Eder M., Miyajima A. et al. (1994) JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 14: 4335-4341
20. Kiuchi N., Nakajima K., Ichiba M., Fukada T., Narimatsu M., Mizuno K. et al. (1999) STAT3 is required for the gp130-mediated full activation of the c-myc gene. J. Exp. Med. 189: 63-73
21. Fujii H., Nakagawa Y., Schindler U., Kawahara A., Mori H., Gouilleux F. et al. (1995) Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. Proc. Natl. Acad. Sci. USA 92: 5482-5486
22. Friedmann M. C., Migone T. S., Russell S. M. and Leonard W. J. (1996) Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl. Acad. Sci. USA 93: 2077-2082
23. Chretien S., Varlet P., Verdier F., Gobert S., Cartron J. P. and Gisselbrecht S. (1996) Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation. EMBO J 15: 4174-4181
24. Damen J. E., Wakao H., Miyajima A., Krosl J., Humphries R. K., Cutler R. L. et al. (1995) Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J 14: 5557-5568
25. Gobert S., Chretien S., Gouilleux F., Muller O., Pallard C., Dusanter-Fourt I. et al. (1996) Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J. 15: 2434-2441
26. Quelle F. W., Wang D., Nosaka T., Thierfelder W. E., Stravopodis D., Weinstein Y. et al. (1996) Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 16: 1622-1631
27. Yamamura Y., Senda H., Kageyama Y., Matsuzaki T., Noda M., Ikawa Y. et al. (1998) Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells. Mol. Cell. Biol. 18: 1172-1180
28. Okajima Y., Matsumura I., Nishiura T., Hashimoto K., Yoshida H., Ishikawa J. et al. (1998) Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5. J. Biol. Chem. 273: 22877-22883
29. Mui A. L., Wakao H., Kinoshita T., Kitamura T. and Miyajima A. (1996) Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J. 15: 2425-2433
30. Okuda K., Smith L., Griffin J. D. and Foster R. (1997) Signaling functions of the tyrosine residues in the betac chain of the granulocyte-macrophage colony-stimulating factor receptor. Blood 90: 4759-4766
31. Barahmand-Pour F., Meinke A., Groner B, and Decker T. (1998) Jak2-Stat5 interactions analyzed in yeast. J. Biol. Chem. 273: 12567-12575
32. Flores-Morales A., Pircher T. J., Silvennoinen O., Gustafsson J. A., Sanchez-Gomez M., Norstedt G. et al. (1998) In vitro interaction between STAT 5 and JAK 2: dependence upon phosphorylation status of STAT 5 and JAK 2. Mol. Cell. Endocrinol. 138: 1-10
33. Welte T., Leitenberg D., Dittel B. N., al-Ramadi B. K., Xie B., Chin Y. C. et al. (1999) STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science 283: 222-225
34. Liu X., Robinson G. W., Wagner K. U., Garrett L., Wynshaw-Boris A. and Hennighausen L. (1997) Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11: 179-186
35. Teglund S., McKay C., Schuetz E., van Deursen J. M., Stravopodis D., Wang D. et al. (1998) Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93: 841-850
36. Udy G. B., Towers R. P., Snell R. G., Wilkins R. J., Park S. H., Ram P. A. et al. (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 94: 7239-7244
37. Feldman G. M., Rosenthal L. A., Liu X., Hayes M. P., Wynshaw-Boris A., Leonard W. J. et al. (1997) STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood 90: 1768-1776
38. John S., Robbins C. M. and Leonard W. J. (1996) An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5. Elf-1, HMG-I(Y) and a GATA family protein. EMBO J. 15: 5627-5635
39. Lecine P., Algarte M., Rameil P., Beadling C., Bucher P., Nabholz M. et al. (1996) Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor alpha gene [published erratum appears in Mol. Cell. Biol. (1997) 17: 2351]. Mol. Cell. Biol. 16: 6829-6840
40. Kaplan M. H., Schindler U., Smiley S. T. and Grusby M. J. (1996) Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4: 313-319
41. Shimoda K., van Deursen J., Sangster M. Y., Sarawar S. R., Carson R. T., Tripp R. A. et al. (1996) Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380: 630-633
42. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S. et al. (1996) Essential role of Stat6 in IL-4 signalling. Nature 380: 627-630
43. Keegan A. D., Nelms K., White M., Wang L. M., Pierce J. H. and Paul W. E. (1994) An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76: 811-820
44. Quelle F. W., Shimoda K., Thierfelder W., Fischer C., Kim A., Ruben S. M. et al. (1995) Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15: 3336-3343
45. Ryan J. J., McReynolds L. J., Keegan A., Wang L. H., Garfein F., Rothman P. et al. (1996) Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4: 123-132
46. Wang L. M., Myers M. G. Jr, Sun X. J., Aaronson S. A., White M. and Pierce J. H. (1993) IRS-1: essential for insulin-and IL-4-stimulated mitogenesis in hematopoietic cells. Science 261: 1591-1594
47. Kaplan M. H., Daniel C., Schindler U. and Grusby M. J. (1998) Stat proteins control lymphocyte proliferation by regulating p27Kipl expression. Mol. Cell. Biol. 18: 1996-2003
48. Kaplan M. H., Sun Y. L., Hoey T. and Grusby M. J. (1996) Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382: 174-177
49. Thierfelder W. E., van Deursen J. M., Yamamoto K., Tripp R. A., Sarawar S. R., Carson R. T. et al. (1996) Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382: 171-174
50. Yamanaka Y., Nakajima K., Fukada T., Hibi M. and Hirano T. (1996) Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J. 15: 1557-1565
51. Minami M., Wei S., Takeda K., Matsumoto M., Kishimoto T. et al. (1996) STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a mycloid cell line. Proc. Natl. Acad. Sci. USA 93: 3963-3966
52. Nakajima K., Yamanaka Y., Nakae K., Kojima H., Ichiba M., Kiuchi N. et al. (1996) A central role for Stat3 in IL-6-induced regulation of growth and differentiation in MI leukemia cells. EMBO J. 15: 3651-3658
53. Faris M., Kokot N., Stahl N. and Nel A. E. (1997) Involvement of Stat3 in interleukin-6-induced IgM production in a human B-cell line. Immunology 90: 350-357
54. Shimozaki K., Nakajima K., Hirano T. and Nagata S. (1997) Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of mycloid cells. J. Biol. Chem. 272: 25184-25189
55. Yoshikawa A., Murakami H. and Nagata S. (1995) Distinct signal transduction through the tyrosine-containing domains of the granulocyte colony-stimulating factor receptor. EMBO J. 14: 5288-5296
56. Bonni A., Sun Y., Nadal-Viscens M., Bhatt A., Frank D. A., Rozovsky I. et al. (1997) Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278: 477-483
57. Rajan P. and McKay R. D. (1998) Multiple routes to astrocytic differentiation in the CNS. J. Neurosci. 18: 3620-3629
58. Boccaccio C., Ando M., Tamagnone L., Bardelli A., Michieli P., Battistini C. et al. (1998) Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391: 285-288
59. Kunisada K., Tone E., Fujio Y., Matsui H., Yamauchi-Takihara K. and Kishimoto T. (1998) Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98: 346-352
60. Nemetz C. and Hocke G. M. (1998) Transcription factor Stat5 is an early marker of differentiation of murine embryonic stem cells. Differentiation 62: 213-220
61. Takeda T., Kurachi H., Yamamoto T., Homma H., Adachi K., Morishige K. et al. (1997) Alternative signaling mechanism of leukemia inhibitory factor responsiveness in a differentiating embryonal carcinoma cell. Endocrinology 138: 2689-2696
62. Kirito K., Uchida M., Yamada M., Miura Y. and Komatsu N. (1997) A distinct function of STAT proteins in erythropoietin signal transduction. J. Biol. Chem. 272: 16507-16513
63. Miura Y., Kirito K. and Komatsu N. (1998) Regulation of both erythroid and megakaryocytic differentiation of a human leukemia cell line, UT-7. Acta Haematol 99: 180-184
64. Kirito K., Uchida M., Takatoku M., Nakajima K., Hirano T., Miura Y. et al. (1998) A novel function of Stat1 and Stat3 proteins in erythropoietin-induced erythroid differentiation of a human leukemia cell line. Blood 92: 462-471
65. Schaefer T. S., Sanders L. K. and Nathans D. (1995) Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. Proc. Natl. Acad. Sci. USA 92: 9097-9101
66. Schaefer T. S., Sanders L. K., Park O. K. and Nathans D. (1997) Functional differences between Stat3alpha and Stat3beta. Mol. Cell. Biol. 17: 5307-5316
67. Caldenhoven E., van Dijk T. B., Solari R., Armstrong J., Raaijmakers J. A. M., Lammers J. W. J. et al. (1996) STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J. Biol. Chem. 271: 13221-13227
68. Chakraborty A., White S. M., Schaefer T. S., Ball E. D., Dyer K. F. and Tweardy D. J. (1996) Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human mycloid cells. Blood 88: 2442-2449
69. Liu X., Robinson G. W. and Hennighausen L. (1996) Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol. Endocrinol. 10: 1496-1506
70. Philp J. A., Burdon T. G. and Watson C. J. (1996) Differential activation of STATs 3 and 5 during mammary gland development. FEBS Lett. 396: 77-80
71. Piekorz R. P., Rinke R., Gouilleux F., Neumann B., Groner B. and Hocke G. M. (1998) Modulation of the activation status of Stat5a during LIF-induced differentiation of MI myeloid leukemia cells. Biochim. Biophys. Acta 1402: 313-323
72. Eilers A., Baccarini M., Horn F., Hipskind R. A., Schindler C. and Decker T. (1994) A factor induced by differentiation signals in cells of the macrophage lineage binds to the gamma interferon activation site. Mol. Cell. Biol. 14: 1364-1373
73. Meinke A., Barahmand-Pour F., Wohrl S., Stoiber D. and Decker T. (1996) Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol. Cell. Biol. 16: 6937-6944
74. Woldman I., Mellitzer G., Kieslinger M., Buchhart D., Meinke A. and Beug H. (1997) STAT5 involvement in the differentiation response of primary chicken myeloid progenitor cells 10 chicken myclomonocytic growth factor. J. Immunol. 159: 877-886
75. Matsumura I., Ishikawa J., Nakajima K., Oritani K., Tomiyama Y. and Miyagawa J. (1997) Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5. Mol. Cell. Biol. 17: 2933-2943
76. Drachman J. G., Sabath D. F., Fox N. E. and Kaushansky K. (1997) Thrombopoietin signal transduction in purified murine megakaryocytes. Blood 89: 483-492
77. Wakao H., Chida LX, Damen J. E., Krystal G. and Miyajima A. (1997) A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis. Biochem. Biophys. Res. Commun. 234: 198-205
78. Gregory R. C., Jiang N., Todokoro K., Crouse J., Pacifici R. E. and Wojchowski D. M. (1998) Erythropoietin receptor and STAT5-specific pathways promote SKT6 cell hemoglobinization. Blood 92: 1104-1108
79. Maruyama K., Miyata K. and Yoshimura A. (1994) Proliferation and erythroid differentiation through the cytoplasmic domain of the erythropoietin receptor. J. Biol. Chem. 269: 5976-5980
80. Iwatsuki K., Endo T., Misawa H., Yokouchi M., Matsumoto A., Ohtsubo M. et al. (1997) STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line. J. Biol. Chem. 272: 8149-8152
81. Carroll M., Mathey-Prevot B. and D'Andrea A. (1994) Differentiation domains of the erythropoietin receptor. Proc. Soc. Exp. Biol. Med. 206: 289-294
82. Chiba T., Nagata Y., Machide M., Kishi A., Amanuma H., Sugiyama M. et al. (1993) Tyrosine kinase activation through the extracellular domains of cytokine receptors. Nature 362: 646-648
83. Klingmuller U., Wu H., Hsiao J. G., Toker A., Duckworth B. C., Cantley L. C. et al. (1997) Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc. Natl. Acad. Sci. USA 94: 3016-3021
84. Mellitzer G., Wessely O., Decker T., Meinke A., Hayman M. J. and Beug H. (1996) Activation of Stat 5b in erythroid progenitors correlates with the ability of ErbB to induce sustained cell proliferation. Proc. Natl. Acad. Sci. USA 93: 9600-9605
85. Pless M., Norga K., Carroll M., Heim M. H., D'Andrea A. D. and Mathey-Prevot B. (1997) Receptors that induce erythroid differentiation of Ba/F3 cells: structural requirements and effect on STAT5 binding. Blood 89: 3175-3185
86. Zheng W. and Flavell R. A. (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596
87. Krosl J., Damen J. E., Krystal G. and Humphries R. K. (1996) Interleukin-3 (IL-3) inhibits erythropoietin-induced differentiation in Ba/F3 cells via the IL-3 receptor alpha subunit. J. Biol. Chem. 271: 27432-27437
88. Al-Shami A., Mahanna W. and Naccache P. H. (1998) Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils: selective activation of Jak2, Stat3, and Stat5b. J. Biol. Chem. 273: 1058-1063
89. Wang D., Stravopodis D., Teglund S., Kitazawa J. and Ihle J. N. (1996) Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 16: 6141-6148
90. Azam M., Erdjument-Bromage H., Kreider B. L., Xia M., Quelle F., Basu R. et al. (1995) Interleukin-3 signals through multiple isoforms of Stat5. EMBO J 14: 1402-1411
91. Azam M., Lee C., Strehlow I. and Schindler C. (1997) Functionally distinct isoforms of STAT5 arc generated by protein processing. Immunity 6: 691-701
92. Rosen R. L., Winestock K. D., Chen G., Liu A., Hennighausen L. and Finbloom D. S. (1996) Granulocyte-macrophage colony-stimulating factor preferentially activates the 94-kD STAT5A and an 80-kD STAT5A isoform in human peripheral blood monocytes. Blood 88: 1206-1214
93. Lokuta M. A., McDowell M. A. and Paulnock D. M. (1998) Identification of an additional isoform of STAT5 expressed in immature macrophages. J. Immunol. 161: 1594-1597
94. Welte T., Koch F., Schuler G., Lechner J., Doppler W. and Heufler C. (1997) Granulocyte-macrophage colony-stimulating factor induces a unique set of STAT factors in murine dendritic cells. Eur. J. Immunol. 27: 2737-2740
95. Kirken R. A., Malabarba M. G., Xu J., Liu X., Farrar W. L. and Hennighausen L. (1997) Prolactin stimulates serine/tyrosine phosphorylation and formation of heterocomplexes of multiple Stat5 isoforms in Nb2 lymphocytes. J. Biol. Chem. 272: 14098-14103
96. Luo G. and Yu-Lee L. (1997) Transcriptional inhibition by Stat5. Differential activities at growth- related versus differentiation-specific promoters. J. Biol. Chem. 272: 26841-26849
97. Moriggl R., Gouilleux-Gruart V., Jahne R., Berchtold S., Gartmann C., Liu X. et al. (1996) Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol. Cell. Biol. 16: 5691-5700
98. Kamogawa Y., Minasi L. A., Carding S. R., Bottomly K. and Flavell R. A. (1993) The relationship of IL-4- and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 75: 985-995
99. Ouyang W., Ranganath S. H., Weindel K., Bhattacharya D., Murphy T. L., Sha W. C. et al. (1998) Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9: 745-755
100. Ranganath S., Ouyang W., Bhattarcharya D., Sha W. C., Grupe A., Peltz G. et al. (1998) GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161: 3822-3826
101. Zhang D. H., Yang L. and Ray A. (1998) Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J. Immunol. 161: 3817-3821
102. Barbulescu K., Becker C., Schlaak J. F., Schmitt E., Meyer zum Buschenfelde K. H. and Neurath M. F. (1998) IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4 + T lymphocytes. J. Immunol. 160: 3642-3647
103. Kamogawa Y., Lee H. J., Johnston J. A., McMahon M., O'Garra A. and Arai N. (1998) A conditionally active form of STAT6 can mimic certain effects of IL-4. J. Immunol. 161: 1074-1077
104. Kinoshita T., Yokota T., Arai K. and Miyajima A. (1995) Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J. 14: 266-275
105. Datta S. R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y. et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery. Cell 91: 231-241
106. Vella A., Teague T. K., Ihle J., Kappler J. and Marrack P. (1997) Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells; stat6 is probably not required for the effect of IL-4. J. Exp. Med. 186: 325-330
107. Zamorano J. and Keegan A. D. (1998) Regulation of apoptosis by tyrosine-containing domains of IL-4R alpha: Y497 and Y713, but not the STAT6-docking tyrosines, signal protection from apoptosis. J. Immunol. 161: 859-867
108. Fukada T., Hibi M., Yamanaka Y., Takahashi-Tezuka M., Fujitani Y., Yamaguchi T. et al. (1996) Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 5: 449-460
109. Takeda K., Kaisho T., Yoshida N., Takeda J., Kishimoto T. and Akira S. (1998) Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell- specific Stat3-deficient mice. J. Immunol. 161: 4652-4660
110. Chin Y. E., Kitagawa M., Kuida K., Flavell R. A. and Fu X. Y. (1997) Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 17: 5328-5337
111. Kumar A., Commane M., Flickinger T. W., Horvath C. M. and Stark G. R. (1997) Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278: 1630-1632
112. Zushi S., Shinomura Y., Kiyohara T., Miyazaki Y., Kondo S., Sugimachi M. et al. (1998) STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells. Int. J. Cancer 78: 326-330
113. Skov S., Nielsen M., Bregenholt S., Odum N. and Claesson M. H. (1998) Activation of Stat-3 is involved in the induction of apoptosis after ligation of major histocompatibility complex class I molecules on human Jurkat T cells. Blood 91: 3566-3573
114. Migone T. S., Lin J. X., Cereseto A., Mulloy J. C., O'Shea J. J., Franchini G. et al. (1995) Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269: 79-81
115. Takemoto S., Mulloy J. C., Cereseto A., Migone T. S., Patel B. K., Matsuoka M. et al. (1997) Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc. Natl. Acad. Sci. USA 94: 13897-13902
116. Nielsen M., Kaltoft K., Nordahl M., Ropke C., Geisler C., Mustelin T. et al. (1997) Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc. Natl. Acad. Sci. USA 94: 6764-6769
117. Wen Z., Zhong Z. and Darnell J. E. Jr (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250
118. Zhang X., Blenis J., Li H. C., Schindler C. and Chen-Kiang S. (1995) Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267: 1990-1994
119. Frank D. A., Mahajan S. and Ritz J. (1997) B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. J. Clin. Invest. 100: 3140-3148
120. Karras J. G., Wang Z., Huo L., Howard R. G., Frank D. A. and Rothstein T. L. (1997) Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J. Exp. Med. 185: 1035-1042
121. Weber-Nordt R. M., Egen C., Wehinger J., Ludwig W., Gouilleux-Gruart V., Mertelsmann R. et al. (1996) Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88: 809-816
122. Xia Z., Baer M. R., Block A. W., Baumann H. and Wetzler M. (1998) Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts. Cancer Res. 58: 3173-3180
123. Chai S. K., Nichols G. L. and Rothman P. (1997) Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. J. Immunol. 159: 4720-4728
124. Carlesso N., Frank D. A. and Griffin J. D. (1996) Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med. 183: 811-820
125. Cao X., Tay A., Guy G. R. and Tan Y. H. (1996) Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell. Biol. 16: 1595-1603